Cohort Event Monitoring (CEM) is a pharmacovigilance method that actively tracks safety events in defined patient populations.
CEM captures adverse events following exposure to a medicinal product in real-world settings. It supports post-authorization safety studies and risk management plans. CEM analyses help identify emerging safety signals and inform regulatory decision-making.